Segments of Business and Geographic Areas - Sales By Segment Of Business (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 29, 2024	Oct. 01, 2023	Sep. 29, 2024	Oct. 01, 2023
Sales by segment of business
Sales to customers	$ 22,471	$ 21,351	$ 66,301	$ 63,764
Percent Change (as a percent)	5.20%		4.00%
U.S.
Sales by segment of business
Sales to customers	$ 12,909	11,996	$ 37,098	34,435
Percent Change (as a percent)	7.60%		7.70%
International
Sales by segment of business
Sales to customers	$ 9,562	9,355	$ 29,203	29,329
Percent Change (as a percent)	2.20%		(0.40%)
Innovative Medicine
Sales by segment of business
Sales to customers	$ 14,580	13,893	$ 42,632	41,037
Percent Change (as a percent)	4.90%		3.90%
Innovative Medicine | U.S.
Sales by segment of business
Sales to customers	$ 8,871	8,249	$ 24,993	23,090
Percent Change (as a percent)	7.50%		8.20%
Innovative Medicine | International
Sales by segment of business
Sales to customers	$ 5,709	5,644	$ 17,639	17,947
Percent Change (as a percent)	1.20%		(1.70%)
Innovative Medicine | Immunology
Sales by segment of business
Sales to customers	$ 4,621	4,849	$ 13,590	13,457
Percent Change (as a percent)	(4.70%)		1.00%
Innovative Medicine | Immunology | U.S.
Sales by segment of business
Sales to customers	$ 3,068	3,193	$ 8,499	8,506
Percent Change (as a percent)	(3.90%)		(0.10%)
Innovative Medicine | Immunology | International
Sales by segment of business
Sales to customers	$ 1,552	1,656	$ 5,090	4,951
Percent Change (as a percent)	(6.20%)		2.80%
Innovative Medicine | Immunology | REMICADE
Sales by segment of business
Sales to customers	$ 419	461	$ 1,246	1,410
Percent Change (as a percent)	(9.10%)		(11.60%)
Innovative Medicine | Immunology | REMICADE | U.S.
Sales by segment of business
Sales to customers	$ 281	296	$ 778	849
Percent Change (as a percent)	(5.40%)		(8.50%)
Innovative Medicine | Immunology | REMICADE | U.S. Exports
Sales by segment of business
Sales to customers	$ 27	38	$ 89	112
Percent Change (as a percent)	(28.90%)		(20.50%)
Innovative Medicine | Immunology | REMICADE | International
Sales by segment of business
Sales to customers	$ 112	127	$ 380	449
Percent Change (as a percent)	(11.50%)		(15.40%)
Innovative Medicine | Immunology | SIMPONI / SIMPONI ARIA
Sales by segment of business
Sales to customers	$ 516	629	$ 1,607	1,695
Percent Change (as a percent)	(18.00%)		(5.20%)
Innovative Medicine | Immunology | SIMPONI / SIMPONI ARIA | U.S.
Sales by segment of business
Sales to customers	$ 299	310	$ 820	866
Percent Change (as a percent)	(3.70%)		(5.30%)
Innovative Medicine | Immunology | SIMPONI / SIMPONI ARIA | International
Sales by segment of business
Sales to customers	$ 218	319	$ 787	829
Percent Change (as a percent)	(31.80%)		(5.10%)
Innovative Medicine | Immunology | STELARA
Sales by segment of business
Sales to customers	$ 2,676	2,864	$ 8,012	8,105
Percent Change (as a percent)	(6.60%)		(1.20%)
Innovative Medicine | Immunology | STELARA | U.S.
Sales by segment of business
Sales to customers	$ 1,770	1,912	$ 5,021	5,180
Percent Change (as a percent)	(7.50%)		(3.10%)
Innovative Medicine | Immunology | STELARA | International
Sales by segment of business
Sales to customers	$ 906	951	$ 2,991	2,925
Percent Change (as a percent)	(4.80%)		2.20%
Innovative Medicine | Immunology | TREMFYA
Sales by segment of business
Sales to customers	$ 1,007	891	$ 2,721	2,237
Percent Change (as a percent)	13.00%		21.60%
Innovative Medicine | Immunology | TREMFYA | U.S.
Sales by segment of business
Sales to customers	$ 691	634	$ 1,789	1,490
Percent Change (as a percent)	9.10%		20.10%
Innovative Medicine | Immunology | TREMFYA | International
Sales by segment of business
Sales to customers	$ 316	258	$ 932	747
Percent Change (as a percent)	22.60%		24.70%
Innovative Medicine | Immunology | OTHER IMMUNOLOGY
Sales by segment of business
Sales to customers	$ 1	2	$ 3	9
Percent Change (as a percent)	(45.60%)		(66.80%)
Innovative Medicine | Immunology | OTHER IMMUNOLOGY | U.S.
Sales by segment of business
Sales to customers	$ 1	2	$ 3	9
Percent Change (as a percent)	(45.60%)		(66.80%)
Innovative Medicine | Immunology | OTHER IMMUNOLOGY | International
Sales by segment of business
Sales to customers	$ 0	0	$ 0	0
Percent Change (as a percent)	0.00%		0.00%
Innovative Medicine | Infectious Diseases
Sales by segment of business
Sales to customers	$ 836	859	$ 2,622	3,566
Percent Change (as a percent)	(2.70%)		(26.50%)
Innovative Medicine | Infectious Diseases | U.S.
Sales by segment of business
Sales to customers	$ 365	360	$ 1,023	1,147
Percent Change (as a percent)	1.50%		(10.80%)
Innovative Medicine | Infectious Diseases | International
Sales by segment of business
Sales to customers	$ 471	500	$ 1,599	2,420
Percent Change (as a percent)	(5.70%)		(33.90%)
Innovative Medicine | Infectious Diseases | COVID-19
Sales by segment of business
Sales to customers	$ 1	41	$ 198	1,073
Percent Change (as a percent)	(97.70%)		(81.60%)
Innovative Medicine | Infectious Diseases | COVID-19 | U.S.
Sales by segment of business
Sales to customers	$ 0	0	$ 0	0
Percent Change (as a percent)	0.00%		0.00%
Innovative Medicine | Infectious Diseases | COVID-19 | International
Sales by segment of business
Sales to customers	$ 1	41	$ 198	1,073
Percent Change (as a percent)	(97.70%)		(81.60%)
Innovative Medicine | Infectious Diseases | EDURANT / rilpivirine
Sales by segment of business
Sales to customers	$ 330	297	$ 950	843
Percent Change (as a percent)	11.50%		12.70%
Innovative Medicine | Infectious Diseases | EDURANT / rilpivirine | U.S.
Sales by segment of business
Sales to customers	$ 8	9	$ 24	26
Percent Change (as a percent)	(15.80%)		(10.00%)
Innovative Medicine | Infectious Diseases | EDURANT / rilpivirine | International
Sales by segment of business
Sales to customers	$ 323	287	$ 926	816
Percent Change (as a percent)	12.30%		13.50%
Innovative Medicine | Infectious Diseases | PREZISTA / PREZCOBIX / REZOLSTA / SYMTUZA
Sales by segment of business
Sales to customers	$ 449	447	$ 1,305	1,415
Percent Change (as a percent)	0.60%		(7.80%)
Innovative Medicine | Infectious Diseases | PREZISTA / PREZCOBIX / REZOLSTA / SYMTUZA | U.S.
Sales by segment of business
Sales to customers	$ 355	345	$ 990	1,105
Percent Change (as a percent)	2.80%		(10.50%)
Innovative Medicine | Infectious Diseases | PREZISTA / PREZCOBIX / REZOLSTA / SYMTUZA | International
Sales by segment of business
Sales to customers	$ 94	102	$ 315	310
Percent Change (as a percent)	(6.90%)		1.80%
Innovative Medicine | Infectious Diseases | OTHER INFECTIOUS DISEASES
Sales by segment of business
Sales to customers	$ 55	74	$ 169	235
Percent Change (as a percent)	(25.40%)		(28.00%)
Innovative Medicine | Infectious Diseases | OTHER INFECTIOUS DISEASES | U.S.
Sales by segment of business
Sales to customers	$ 3	5	$ 10	15
Percent Change (as a percent)	(52.20%)		(37.70%)
Innovative Medicine | Infectious Diseases | OTHER INFECTIOUS DISEASES | International
Sales by segment of business
Sales to customers	$ 53	69	$ 160	220
Percent Change (as a percent)	(23.20%)		(27.40%)
Innovative Medicine | Neuroscience
Sales by segment of business
Sales to customers	$ 1,755	1,742	$ 5,340	5,339
Percent Change (as a percent)	0.80%		0.00%
Innovative Medicine | Neuroscience | U.S.
Sales by segment of business
Sales to customers	$ 1,094	1,036	$ 3,250	3,043
Percent Change (as a percent)	5.60%		6.80%
Innovative Medicine | Neuroscience | International
Sales by segment of business
Sales to customers	$ 662	706	$ 2,090	2,296
Percent Change (as a percent)	(6.20%)		(8.90%)
Innovative Medicine | Neuroscience | CONCERTA / methylphenidate
Sales by segment of business
Sales to customers	$ 142	189	$ 482	603
Percent Change (as a percent)	(24.80%)		(20.00%)
Innovative Medicine | Neuroscience | CONCERTA / methylphenidate | U.S.
Sales by segment of business
Sales to customers	$ 26	57	$ 101	191
Percent Change (as a percent)	(55.00%)		(47.50%)
Innovative Medicine | Neuroscience | CONCERTA / methylphenidate | International
Sales by segment of business
Sales to customers	$ 117	133	$ 382	412
Percent Change (as a percent)	(11.90%)		(7.30%)
Innovative Medicine | Neuroscience | INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA
Sales by segment of business
Sales to customers	$ 1,049	1,029	$ 3,159	3,104
Percent Change (as a percent)	1.90%		1.80%
Innovative Medicine | Neuroscience | INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA | U.S.
Sales by segment of business
Sales to customers	$ 780	730	$ 2,329	2,164
Percent Change (as a percent)	6.80%		7.60%
Innovative Medicine | Neuroscience | INVEGA SUSTENNA / XEPLION / INVEGA TRINZA / TREVICTA | International
Sales by segment of business
Sales to customers	$ 269	299	$ 830	940
Percent Change (as a percent)	(10.10%)		(11.70%)
Innovative Medicine | Neuroscience | SPRAVATO
Sales by segment of business
Sales to customers	$ 284	183	$ 780	483
Percent Change (as a percent)	54.90%		61.50%
Innovative Medicine | Neuroscience | SPRAVATO | U.S.
Sales by segment of business
Sales to customers	$ 243	154	$ 660	409
Percent Change (as a percent)	56.80%		61.20%
Innovative Medicine | Neuroscience | SPRAVATO | International
Sales by segment of business
Sales to customers	$ 42	29	$ 120	74
Percent Change (as a percent)	44.60%		62.90%
Innovative Medicine | Neuroscience | OTHER NEUROSCIENCE
Sales by segment of business
Sales to customers	$ 281	340	$ 920	1,149
Percent Change (as a percent)	(17.40%)		(19.90%)
Innovative Medicine | Neuroscience | OTHER NEUROSCIENCE | U.S.
Sales by segment of business
Sales to customers	$ 46	94	$ 161	278
Percent Change (as a percent)	(51.40%)		(42.10%)
Innovative Medicine | Neuroscience | OTHER NEUROSCIENCE | International
Sales by segment of business
Sales to customers	$ 235	245	$ 759	870
Percent Change (as a percent)	(4.40%)		(12.80%)
Innovative Medicine | Oncology
Sales by segment of business
Sales to customers	$ 5,380	4,533	$ 15,284	13,043
Percent Change (as a percent)	18.70%		17.20%
Innovative Medicine | Oncology | U.S.
Sales by segment of business
Sales to customers	$ 2,816	2,219	$ 7,835	6,177
Percent Change (as a percent)	26.90%		26.80%
Innovative Medicine | Oncology | International
Sales by segment of business
Sales to customers	$ 2,565	2,313	$ 7,450	6,865
Percent Change (as a percent)	10.90%		8.50%
Innovative Medicine | Oncology | CARVYKTI
Sales by segment of business
Sales to customers	$ 286	152	$ 629	341
Percent Change (as a percent)	87.70%		84.30%
Innovative Medicine | Oncology | CARVYKTI | U.S.
Sales by segment of business
Sales to customers	$ 258	140	$ 565	324
Percent Change (as a percent)	84.90%		74.60%
Innovative Medicine | Oncology | CARVYKTI | International
Sales by segment of business
Sales to customers	$ 27	12	$ 63	17
Innovative Medicine | Oncology | DARZALEX
Sales by segment of business
Sales to customers	$ 3,016	2,499	$ 8,586	7,194
Percent Change (as a percent)	20.70%		19.30%
Innovative Medicine | Oncology | DARZALEX | U.S.
Sales by segment of business
Sales to customers	$ 1,684	1,369	$ 4,789	3,882
Percent Change (as a percent)	23.00%		23.40%
Innovative Medicine | Oncology | DARZALEX | International
Sales by segment of business
Sales to customers	$ 1,332	1,130	$ 3,797	3,312
Percent Change (as a percent)	17.90%		14.60%
Innovative Medicine | Oncology | ERLEADA
Sales by segment of business
Sales to customers	$ 790	631	$ 2,215	1,740
Percent Change (as a percent)	25.40%		27.30%
Innovative Medicine | Oncology | ERLEADA | U.S.
Sales by segment of business
Sales to customers	$ 337	288	$ 940	778
Percent Change (as a percent)	17.10%		20.80%
Innovative Medicine | Oncology | ERLEADA | International
Sales by segment of business
Sales to customers	$ 453	342	$ 1,275	961
Percent Change (as a percent)	32.40%		32.60%
Innovative Medicine | Oncology | IMBRUVICA
Sales by segment of business
Sales to customers	$ 753	808	$ 2,307	2,476
Percent Change (as a percent)	(6.80%)		(6.80%)
Innovative Medicine | Oncology | IMBRUVICA | U.S.
Sales by segment of business
Sales to customers	$ 259	264	$ 770	796
Percent Change (as a percent)	(1.90%)		(3.20%)
Innovative Medicine | Oncology | IMBRUVICA | International
Sales by segment of business
Sales to customers	$ 494	545	$ 1,537	1,681
Percent Change (as a percent)	(9.20%)		(8.50%)
Innovative Medicine | Oncology | Tecvayli
Sales by segment of business
Sales to customers	$ 135	112	$ 403	269
Percent Change (as a percent)	20.60%		49.60%
Innovative Medicine | Oncology | Tecvayli | U.S.
Sales by segment of business
Sales to customers	$ 105	93	$ 310	232
Percent Change (as a percent)	13.50%		34.00%
Innovative Medicine | Oncology | Tecvayli | International
Sales by segment of business
Sales to customers	$ 30	19	$ 93	37
Percent Change (as a percent)	54.20%
Innovative Medicine | Oncology | ZYTIGA / abiraterone acetate
Sales by segment of business
Sales to customers	$ 150	214	$ 496	686
Percent Change (as a percent)	(30.00%)		(27.80%)
Innovative Medicine | Oncology | ZYTIGA / abiraterone acetate | U.S.
Sales by segment of business
Sales to customers	$ 5	16	$ 25	41
Percent Change (as a percent)	(66.00%)		(38.00%)
Innovative Medicine | Oncology | ZYTIGA / abiraterone acetate | International
Sales by segment of business
Sales to customers	$ 144	199	$ 470	646
Percent Change (as a percent)	(27.10%)		(27.10%)
Innovative Medicine | Oncology | OTHER ONCOLOGY
Sales by segment of business
Sales to customers	$ 250	117	$ 649	336
Percent Change (as a percent)			93.40%
Innovative Medicine | Oncology | OTHER ONCOLOGY | U.S.
Sales by segment of business
Sales to customers	168	50	$ 435	125
Innovative Medicine | Oncology | OTHER ONCOLOGY | International
Sales by segment of business
Sales to customers	$ 83	67	$ 214	211
Percent Change (as a percent)	24.80%		2.00%
Innovative Medicine | Pulmonary Hypertension
Sales by segment of business
Sales to customers	$ 1,102	954	$ 3,190	2,798
Percent Change (as a percent)	15.60%		14.00%
Innovative Medicine | Pulmonary Hypertension | U.S.
Sales by segment of business
Sales to customers	$ 815	680	$ 2,324	1,964
Percent Change (as a percent)	20.00%		18.40%
Innovative Medicine | Pulmonary Hypertension | International
Sales by segment of business
Sales to customers	$ 287	274	$ 866	835
Percent Change (as a percent)	4.50%		3.70%
Innovative Medicine | Pulmonary Hypertension | OPSUMIT
Sales by segment of business
Sales to customers	$ 571	490	$ 1,639	1,437
Percent Change (as a percent)	16.80%		14.10%
Innovative Medicine | Pulmonary Hypertension | OPSUMIT | U.S.
Sales by segment of business
Sales to customers	$ 406	323	$ 1,135	924
Percent Change (as a percent)	25.40%		22.80%
Innovative Medicine | Pulmonary Hypertension | OPSUMIT | International
Sales by segment of business
Sales to customers	$ 165	166	$ 504	512
Percent Change (as a percent)	(0.20%)		(1.60%)
Innovative Medicine | Pulmonary Hypertension | UPTRAVI
Sales by segment of business
Sales to customers	$ 458	402	$ 1,352	1,163
Percent Change (as a percent)	14.20%		16.30%
Innovative Medicine | Pulmonary Hypertension | UPTRAVI | U.S.
Sales by segment of business
Sales to customers	$ 379	336	$ 1,120	978
Percent Change (as a percent)	12.70%		14.50%
Innovative Medicine | Pulmonary Hypertension | UPTRAVI | International
Sales by segment of business
Sales to customers	$ 80	66	$ 232	185
Percent Change (as a percent)	21.80%		25.50%
Innovative Medicine | Pulmonary Hypertension | Other
Sales by segment of business
Sales to customers	$ 72	63	$ 199	199
Percent Change (as a percent)	15.00%		0.30%
Innovative Medicine | Pulmonary Hypertension | Other | U.S.
Sales by segment of business
Sales to customers	$ 32	20	$ 70	61
Percent Change (as a percent)	54.00%		14.00%
Innovative Medicine | Pulmonary Hypertension | Other | International
Sales by segment of business
Sales to customers	$ 40	42	$ 129	137
Percent Change (as a percent)	(3.90%)		(5.80%)
Innovative Medicine | Cardiovascular / Metabolism / Other
Sales by segment of business
Sales to customers	$ 884	957	$ 2,605	2,834
Percent Change (as a percent)	(7.60%)		(8.10%)
Innovative Medicine | Cardiovascular / Metabolism / Other | U.S.
Sales by segment of business
Sales to customers	$ 713	763	$ 2,061	2,254
Percent Change (as a percent)	(6.50%)		(8.50%)
Innovative Medicine | Cardiovascular / Metabolism / Other | International
Sales by segment of business
Sales to customers	$ 170	194	$ 543	580
Percent Change (as a percent)	(11.90%)		(6.40%)
Innovative Medicine | Cardiovascular / Metabolism / Other | Other
Sales by segment of business
Sales to customers	$ 292	332	$ 908	994
Percent Change (as a percent)	(12.00%)		(8.70%)
Innovative Medicine | Cardiovascular / Metabolism / Other | Other | U.S.
Sales by segment of business
Sales to customers	$ 121	139	$ 364	414
Percent Change (as a percent)	(12.20%)		(11.90%)
Innovative Medicine | Cardiovascular / Metabolism / Other | Other | International
Sales by segment of business
Sales to customers	$ 170	194	$ 543	580
Percent Change (as a percent)	(11.90%)		(6.40%)
Innovative Medicine | Cardiovascular / Metabolism / Other | XARELTO
Sales by segment of business
Sales to customers	$ 592	625	$ 1,697	1,840
Percent Change (as a percent)	(5.20%)		(7.80%)
Innovative Medicine | Cardiovascular / Metabolism / Other | XARELTO | U.S.
Sales by segment of business
Sales to customers	$ 592	625	$ 1,697	1,840
Percent Change (as a percent)	(5.20%)		(7.80%)
Innovative Medicine | Cardiovascular / Metabolism / Other | XARELTO | International
Sales by segment of business
Sales to customers	$ 0	0	$ 0	0
Percent Change (as a percent)	0.00%		0.00%
MEDTECH
Sales by segment of business
Sales to customers	$ 7,891	7,458	$ 23,669	22,727
Percent Change (as a percent)	5.80%		4.10%
MEDTECH | U.S.
Sales by segment of business
Sales to customers	$ 4,038	3,747	$ 12,105	11,345
Percent Change (as a percent)	7.80%		6.70%
MEDTECH | International
Sales by segment of business
Sales to customers	$ 3,853	3,711	$ 11,564	11,382
Percent Change (as a percent)	3.90%		1.60%
MEDTECH | Cardiovascular
Sales by segment of business
Sales to customers	$ 1,966	1,558	$ 5,645	4,681
Percent Change (as a percent)	26.20%		20.60%
MEDTECH | Cardiovascular | U.S.
Sales by segment of business
Sales to customers	$ 1,148	891	$ 3,292	2,662
Percent Change (as a percent)	28.60%		23.60%
MEDTECH | Cardiovascular | International
Sales by segment of business
Sales to customers	$ 819	667	$ 2,353	2,019
Percent Change (as a percent)	22.80%		16.50%
MEDTECH | ELECTROPHYSIOLOGY
Sales by segment of business
Sales to customers	$ 1,279	1,161	$ 3,946	3,449
Percent Change (as a percent)	10.20%		14.40%
MEDTECH | ELECTROPHYSIOLOGY | U.S.
Sales by segment of business
Sales to customers	$ 660	611	$ 2,057	1,791
Percent Change (as a percent)	7.90%		14.80%
MEDTECH | ELECTROPHYSIOLOGY | International
Sales by segment of business
Sales to customers	$ 619	549	$ 1,889	1,658
Percent Change (as a percent)	12.70%		14.00%
MEDTECH | ABIOMED
Sales by segment of business
Sales to customers	$ 362	311	$ 1,112	966
Percent Change (as a percent)	16.30%		15.10%
MEDTECH | ABIOMED | U.S.
Sales by segment of business
Sales to customers	$ 293	254	$ 905	790
Percent Change (as a percent)	15.40%		14.50%
MEDTECH | ABIOMED | International
Sales by segment of business
Sales to customers	$ 68	57	$ 207	176
Percent Change (as a percent)	20.10%		17.70%
MEDTECH | Shockwave
Sales by segment of business
Sales to customers	$ 229	0	$ 306	0
MEDTECH | Shockwave | U.S.
Sales by segment of business
Sales to customers	163	0	240	0
MEDTECH | Shockwave | International
Sales by segment of business
Sales to customers	66	0	66	0
MEDTECH | Other Cardiovascular
Sales by segment of business
Sales to customers	$ 96	87	$ 281	267
Percent Change (as a percent)	10.40%		5.30%
MEDTECH | Other Cardiovascular | U.S.
Sales by segment of business
Sales to customers	$ 30	26	$ 89	81
Percent Change (as a percent)	16.70%		10.60%
MEDTECH | Other Cardiovascular | International
Sales by segment of business
Sales to customers	$ 66	61	$ 192	186
Percent Change (as a percent)	7.70%		3.00%
MEDTECH | Orthopaedics
Sales by segment of business
Sales to customers	$ 2,191	2,164	$ 6,843	6,674
Percent Change (as a percent)	1.20%		2.50%
MEDTECH | Orthopaedics | U.S.
Sales by segment of business
Sales to customers	$ 1,359	1,349	$ 4,229	4,100
Percent Change (as a percent)	0.70%		3.20%
MEDTECH | Orthopaedics | International
Sales by segment of business
Sales to customers	$ 832	815	$ 2,614	2,574
Percent Change (as a percent)	2.00%		1.50%
MEDTECH | Orthopaedics | HIPS
Sales by segment of business
Sales to customers	$ 381	375	$ 1,220	1,162
Percent Change (as a percent)	1.70%		5.00%
MEDTECH | Orthopaedics | HIPS | U.S.
Sales by segment of business
Sales to customers	$ 250	239	$ 785	730
Percent Change (as a percent)	4.80%		7.50%
MEDTECH | Orthopaedics | HIPS | International
Sales by segment of business
Sales to customers	$ 131	136	$ 435	432
Percent Change (as a percent)	(3.60%)		0.60%
MEDTECH | Orthopaedics | KNEES
Sales by segment of business
Sales to customers	$ 352	338	$ 1,147	1,069
Percent Change (as a percent)	4.00%		7.20%
MEDTECH | Orthopaedics | KNEES | U.S.
Sales by segment of business
Sales to customers	$ 212	207	$ 684	654
Percent Change (as a percent)	2.20%		4.50%
MEDTECH | Orthopaedics | KNEES | International
Sales by segment of business
Sales to customers	$ 140	131	$ 463	415
Percent Change (as a percent)	6.90%		11.50%
MEDTECH | Orthopaedics | TRAUMA
Sales by segment of business
Sales to customers	$ 761	742	$ 2,285	2,238
Percent Change (as a percent)	2.60%		2.10%
MEDTECH | Orthopaedics | TRAUMA | U.S.
Sales by segment of business
Sales to customers	$ 497	488	$ 1,499	1,462
Percent Change (as a percent)	1.80%		2.50%
MEDTECH | Orthopaedics | TRAUMA | International
Sales by segment of business
Sales to customers	$ 265	253	$ 786	775
Percent Change (as a percent)	4.20%		1.40%
MEDTECH | Orthopaedics | SPINE, SPORTS & OTHER
Sales by segment of business
Sales to customers	$ 696	710	$ 2,191	2,205
Percent Change (as a percent)	(1.90%)		(0.60%)
MEDTECH | Orthopaedics | SPINE, SPORTS & OTHER | U.S.
Sales by segment of business
Sales to customers	$ 400	415	$ 1,262	1,254
Percent Change (as a percent)	(3.60%)		0.60%
MEDTECH | Orthopaedics | SPINE, SPORTS & OTHER | International
Sales by segment of business
Sales to customers	$ 296	295	$ 930	952
Percent Change (as a percent)	0.40%		(2.30%)
MEDTECH | Surgery
Sales by segment of business
Sales to customers	$ 2,434	2,479	$ 7,338	7,507
Percent Change (as a percent)	(1.80%)		(2.20%)
MEDTECH | Surgery | U.S.
Sales by segment of business
Sales to customers	$ 983	994	$ 2,965	2,984
Percent Change (as a percent)	(1.10%)		(0.60%)
MEDTECH | Surgery | International
Sales by segment of business
Sales to customers	$ 1,451	1,483	$ 4,373	4,522
Percent Change (as a percent)	(2.20%)		(3.30%)
MEDTECH | Surgery | ADVANCED
Sales by segment of business
Sales to customers	$ 1,109	1,164	$ 3,337	3,504
Percent Change (as a percent)	(4.70%)		(4.80%)
MEDTECH | Surgery | ADVANCED | U.S.
Sales by segment of business
Sales to customers	$ 448	455	$ 1,360	1,365
Percent Change (as a percent)	(1.40%)		(0.40%)
MEDTECH | Surgery | ADVANCED | International
Sales by segment of business
Sales to customers	$ 661	709	$ 1,977	2,139
Percent Change (as a percent)	(6.80%)		(7.60%)
MEDTECH | Surgery | GENERAL
Sales by segment of business
Sales to customers	$ 1,325	1,314	$ 4,001	4,002
Percent Change (as a percent)	0.80%		0.00%
MEDTECH | Surgery | GENERAL | U.S.
Sales by segment of business
Sales to customers	$ 535	540	$ 1,605	1,619
Percent Change (as a percent)	(0.90%)		(0.90%)
MEDTECH | Surgery | GENERAL | International
Sales by segment of business
Sales to customers	$ 791	775	$ 2,397	2,383
Percent Change (as a percent)	2.10%		0.60%
MEDTECH | Vision
Sales by segment of business
Sales to customers	$ 1,300	1,256	$ 3,843	3,864
Percent Change (as a percent)	3.50%		(0.50%)
MEDTECH | Vision | U.S.
Sales by segment of business
Sales to customers	$ 549	512	$ 1,619	1,599
Percent Change (as a percent)	7.20%		1.30%
MEDTECH | Vision | International
Sales by segment of business
Sales to customers	$ 751	744	$ 2,224	2,265
Percent Change (as a percent)	0.90%		(1.80%)
MEDTECH | Vision | CONTACT LENSES / OTHER
Sales by segment of business
Sales to customers	$ 968	928	$ 2,796	2,820
Percent Change (as a percent)	4.20%		(0.90%)
MEDTECH | Vision | CONTACT LENSES / OTHER | U.S.
Sales by segment of business
Sales to customers	$ 441	399	$ 1,288	1,252
Percent Change (as a percent)	10.20%		2.80%
MEDTECH | Vision | CONTACT LENSES / OTHER | International
Sales by segment of business
Sales to customers	$ 527	529	$ 1,508	1,568
Percent Change (as a percent)	(0.30%)		(3.80%)
MEDTECH | Vision | SURGICAL
Sales by segment of business
Sales to customers	$ 333	328	$ 1,048	1,044
Percent Change (as a percent)	1.30%		0.30%
MEDTECH | Vision | SURGICAL | U.S.
Sales by segment of business
Sales to customers	$ 108	112	$ 331	346
Percent Change (as a percent)	(3.60%)		(4.40%)
MEDTECH | Vision | SURGICAL | International
Sales by segment of business
Sales to customers	$ 225	$ 216	$ 717	$ 698
Percent Change (as a percent)	3.90%		2.70%